CRVS vs. AKRO

Last updated Apr 1, 2026

Compare and contrast key facts about Corvus Pharmaceuticals, Inc. (CRVS) and Akero Therapeutics, Inc. (AKRO).

Performance

CRVS vs. AKRO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Corvus Pharmaceuticals, Inc. (CRVS) and Akero Therapeutics, Inc. (AKRO). The values are adjusted to include any dividend payments, if applicable.

CRVS vs. AKRO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
CRVS Corvus Pharmaceuticals, Inc.	90.00%	43.93%	203.98%	107.06%	-64.73%	-32.30%	-34.56%	50.69%
AKRO Akero Therapeutics, Inc.	0.00%	96.44%	19.14%	-57.39%	159.10%	-18.02%	16.24%	21.15%

Fundamentals

Market Cap CRVS : $1.17B AKRO : $4.48B
EPS CRVS : -$0.19 AKRO : -$3.58
PB Ratio CRVS : 19.06 AKRO : 4.68
Total Revenue (TTM) CRVS : $0.00 AKRO : $0.00
Gross Profit (TTM) CRVS : $0.00 AKRO : $0.00
EBITDA (TTM) CRVS : -$42.97M AKRO : -$288.18M

Returns By Period

CRVS

• 1D: 9.18%
• 1M: -19.88%
• YTD: 90.00%
• 6M: 98.51%
• 1Y: 360.06%
• 3Y*: 152.39%
• 5Y*: 36.04%
• 10Y*: 0.26%

AKRO

• 1D: —
• 1M: —
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

CRVS vs. AKRO — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CRVS

CRVS Risk / Return Rank: 96
CRVS Sharpe Ratio Rank: 90
CRVS Sortino Ratio Rank: 99
CRVS Omega Ratio Rank: 97
CRVS Calmar Ratio Rank: 96
CRVS Martin Ratio Rank: 97

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRVS vs. AKRO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Corvus Pharmaceuticals, Inc. (CRVS) and Akero Therapeutics, Inc. (AKRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	CRVS	AKRO	Difference
Sharpe ratio Return per unit of total volatility	1.99	—	—
Sortino ratio Return per unit of downside risk	5.67	—	—
Omega ratio Gain probability vs. loss probability	1.63	—	—
Calmar ratio Return relative to maximum drawdown	6.87	—	—
Martin ratio Return relative to average drawdown	19.77	—	—
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

Sharpe Ratios by Period

	CRVS	AKRO	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.99	—	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.28	—	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.00	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.00	—	—

Correlation

The correlation between CRVS and AKRO is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

CRVS vs. AKRO - Dividend Comparison

Neither CRVS nor AKRO has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

Drawdown Indicators

	CRVS	AKRO	Difference
Max Drawdown Largest peak-to-trough decline	-96.97%	—	—
Max Drawdown (1Y) Largest decline over 1 year	-48.47%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-92.40%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-96.97%	—	—
Current Drawdown Current decline from peak	-42.67%	—	—
Average Drawdown Average peak-to-trough decline	-69.79%	—	—
Ulcer Index Depth and duration of drawdowns from previous peaks	16.84%	—	—

Volatility

Volatility by Period

	CRVS	AKRO	Difference
Volatility (1M) Calculated over the trailing 1-month period	22.82%	—	—
Volatility (6M) Calculated over the trailing 6-month period	109.43%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	182.24%	—	—
Volatility (5Y) Calculated over the trailing 5-year period, annualized	130.57%	—	—
Volatility (10Y) Calculated over the trailing 10-year period, annualized	110.97%	—	—

Financials